🔴 LIVE — Tracking all US product recalls in real-time from FDA, CPSC, NHTSA & USDA
Ad Space — 728×90

Apotex Eye Drop Recall: Sterility Concerns

🟡 MODERATE RISK — CLASS II
Agency: Food and Drug Administration (FDA)  |  Date: 20260325  |  Units: 107,136 vials  |  Risk: Class II

This alert was compiled from official government recall data published by the FDA using automated analysis. All facts are sourced directly from official records. Last verified April 9, 2026.

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1. recalled by Apotex Corp. - Lack of Assurance of Sterility

Stock photo for illustration — not the actual recalled product. Photo by Towfiqu barbhuiya on Unsplash

Did you know that eye drop recalls are on the rise? In recent years, U.S. consumers have seen a concerning number of recalls impacting eye care products. Now, Apotex Corp. is voluntarily recalling nearly 110,000 vials of eye drops sold across the U.S. due to concerns about sterility. If you use Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, it's important to check the details below.

Apotex Corp. Issues Nationwide Recall of Eye Drops

Apotex Corp. has initiated a voluntary product recall in the United States for its Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%. This recall, affecting 107,136 vials, stems from a "lack of assurance of sterility." This means there's a potential risk of contamination that could lead to serious eye infections. The product is packaged in 5 mL bottles and is available by prescription only (Rx Only) and is sterile.

  • Product: Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp.
  • Manufactured for: Apotex Corp., Weston, FL 33326
  • NDC: 60505-0589-1
  • Reason for Recall: Lack of Assurance of Sterility
  • Units Affected: 107,136 vials
  • Distribution: U.S. Nationwide
  • Lot Numbers: VJ8599 (Exp Date 09/30/2026) & VL1668 (Exp Date 01/31/2027)
  • Recall Date: March 25, 2026

This product was distributed nationwide, so if you're an American shopper who uses these eye drops, especially if you reside in states like Florida where Apotex Corp. is located, pay close attention.

Why Sterility Matters & Potential Risks

Nobody wants to find out their eye drops are dangerous. Eye drops must be sterile to prevent introducing harmful bacteria or fungi into the eye. A lack of sterility can lead to infections, which can range from mild discomfort to severe, vision-threatening conditions.

The FDA has classified this as a Class II recall, meaning that use of or exposure to the product could cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. That being said, it's still a serious issue. Apotex Corp. is taking this seriously, although this isn't their first recall. They've had several in recent years, so they're likely acting quickly to mitigate any potential harm to U.S. consumers.

If you experience any of the following symptoms after using the recalled eye drops, contact your doctor immediately:

  • Eye pain
  • Redness
  • Blurred vision
  • Increased sensitivity to light
  • Discharge from the eye

What You Should Do Now

If you think you have purchased the affected eye drops, here's what to do to protect your health:

  1. Stop using the Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution with the specified lot numbers (VJ8599 & VL1668) immediately.
  2. Contact your healthcare provider or ophthalmologist to discuss alternative treatments or medications.
  3. Return the affected product to your pharmacy for proper disposal or follow instructions provided by Apotex Corp. if they offer a return program.
  4. If you experience any adverse reactions, contact your doctor and report the issue to the FDA's MedWatch Adverse Event Reporting program.

Frequently Asked Questions

Q: Why are these eye drops being recalled?

The eye drops are being recalled due to a lack of assurance of sterility, which means there's a potential risk of contamination that could lead to eye infections.

Q: How do I know if my eye drops are part of the recall?

Check the product name, manufacturer (Apotex Corp.), NDC (60505-0589-1) and lot numbers (VJ8599 & VL1668) printed on the packaging and bottle against the information provided in the recall notice.

Q: What should I do if I've already used these eye drops?

If you've used the recalled eye drops, monitor yourself for any signs of eye infection, such as redness, pain, blurred vision, or discharge, and contact your doctor if you experience any of these symptoms.

Q: Will I get a refund for the recalled eye drops?

Contact your pharmacy or Apotex Corp. directly to inquire about their refund or replacement policies for the recalled product.

Q: Where can I find more information about this recall?

You can find more information about the recall on the FDA's website or by contacting Apotex Corp.

This recall was announced by the U.S. Food and Drug Administration (FDA). For the official notice and complete details, visit www.fda.gov.
⚠️ If You Own This Product:
Stop using it right away and follow the steps above. You may be entitled to a full refund, free repair, or replacement at no cost.
This article is based on official recall data from the Food and Drug Administration (FDA). Last verified on April 9, 2026.
Ad Space — In Article